tiprankstipranks
Trending News
More News >
Innovation Pharma (IPIX)
:IPIX
US Market

Innovation Pharmaceuticals (IPIX) Income Statement

Compare
132 Followers

Innovation Pharmaceuticals Income Statement

Last quarter (Q1 2024), Innovation Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Innovation Pharmaceuticals's net income was $-880.00K. See Innovation Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 23Jun 22Jun 21Jun 20Jun 19
Total Revenue
$ 0.00$ 18.00K$ 0.00$ 423.00K$ 0.00
Gross Profit
$ -373.00K$ -364.00K$ -378.00K$ 423.00K$ -371.00K
Operating Expenses
$ 3.11M$ 6.78M$ 9.02M$ 5.06M$ 6.45M
Depreciation and Amortization
$ 373.00K$ 382.00K$ 378.00K$ 373.00K$ 371.00K
EBITDA
$ -2.74M$ -6.54M$ -8.64M$ -6.01M$ -6.11M
Operating Income
$ -3.11M$ -6.92M$ -9.02M$ -4.63M$ -6.45M
Other Income/Expenses
$ -57.00K$ -120.00K$ -4.86M$ -2.01M$ -2.23M
Pretax Income
$ -3.17M$ -7.04M$ -13.87M$ -6.65M$ -8.68M
Net Income
$ -3.17M$ -7.16M$ -18.73M$ -7.01M$ -9.07M
Per Share Metrics
Basic EPS
$ -0.01$ -0.01$ -0.05$ -0.03$ -0.05
Diluted EPS
$ -0.01$ -0.01$ -0.05$ -0.03$ -0.05
Weighted Average Shares Outstanding
505.77M 503.87M 386.16M 237.30M 178.23M
Weighted Average Shares Outstanding (Diluted)
505.77M 503.87M 386.16M 237.30M 178.23M
Currency in USD

Innovation Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis